SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Archit Organosys board to consider dividend

18 May 2016 Evaluate

Archit Organosys has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider and approve the Quarterly / Yearly Audited Financial Results for the aforesaid Quarter/Year end and to consider recommendation of Dividend, if any on the Equity Shares of the Company. In view of above, the trading window will remain close for the Promoters, Directors, Insiders, Designated Persons and the Connected Persons from May 17, 2016 and shall reopen after the expiry of 48 hours from the time the result becomes generally available.

The above information is a part of company’s filings submitted to BSE.

Archit Organosys Share Price

53.30 0.58 (1.10%)
16-Jun-2026 14:33 View Price Chart
Peers
Company Name CMP
SRF 2740.40
BASF India 3455.10
Tata Chemicals 731.35
Pidilite Inds. 1571.10
Deepak Nitrite 1644.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: